20/20 BioLabs moves investor webinar to 2:00 p.m. ET on Sept. 2, 2026 to discuss OneTestTM revenue and commercial expansion
20/20 BioLabs reported second-quarter OneTestTM revenue of $0.7 million, up 47.1% year over year. Gross margin expanded to 41.7% from 30.5%. The company secured a 12-month statewide program in Vermont to screen up to 4,500 firefighters for cancer, along with $520,000 awarded to Maryland fire departments. Management expects incremental testing volume to be absorbed across a largely fixed cost base and said it expects to have tested more than 35,000 firefighters by year-end.